Edward Nash's Stock Ratings

Canaccord Genuity Analyst

Edward Nash is an analyst at Canaccord Genuity. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/28/2024

Overall Average Return

-%

Smart Score

37.9%

Overall Average Return Percentile

-

Number of Ratings

59
Buy NowGet Alert
06/27/2024VRNABuy Now
Verona Pharma
$14.35143.9%$35 → $35MaintainsBuyGet Alert
05/23/2024CRDLBuy Now
Cardiol Therapeutics
$1.99302.01%$6 → $8MaintainsBuyGet Alert
05/13/2024AKROBuy Now
Akero Therapeutics
$23.46138.7%$59 → $56MaintainsBuyGet Alert
05/07/2024TVTXBuy Now
Travere Therapeutics
$8.22118.98%$15 → $18MaintainsBuyGet Alert
04/08/2024IVABuy Now
Inventiva
$2.92584.93%$12 → $20MaintainsBuyGet Alert
03/27/2024RANIBuy Now
Rani Therapeutics Hldgs
$4.00125%$21 → $9MaintainsBuyGet Alert
03/15/2024MDGLBuy Now
Madrigal Pharmaceuticals
$278.9035.17%$338 → $377MaintainsBuyGet Alert
03/13/2024VTYXBuy Now
Ventyx Biosciences
$2.32546.55%$16 → $15MaintainsBuyGet Alert
03/11/2024VTYXBuy Now
Ventyx Biosciences
$2.32589.66%$20 → $16MaintainsBuyGet Alert
03/08/2024MORFBuy Now
Morphic Holding
$34.0793.72%$68 → $66MaintainsBuyGet Alert
03/08/2024MDGLBuy Now
Madrigal Pharmaceuticals
$278.9021.19%$336 → $338MaintainsBuyGet Alert
12/13/2023CORTBuy Now
Corcept Therapeutics
$32.4916.96%$37 → $38MaintainsBuyGet Alert
10/27/2023IVABuy Now
Inventiva
$2.92310.96% → $12Initiates → BuyGet Alert
09/27/2023ICPTBuy Now
Intercept Pharma
$20 → $19DowngradeBuy → HoldGet Alert
09/01/2023VRNABuy Now
Verona Pharma
$14.35143.9% → $35ReiteratesBuy → BuyGet Alert
08/25/2023CORTBuy Now
Corcept Therapeutics
$32.497.73%$34 → $35MaintainsBuyGet Alert
08/03/2023ICPTBuy Now
Intercept Pharma
$19 → $20MaintainsBuyGet Alert
07/18/2023TVTXBuy Now
Travere Therapeutics
$8.22325.79%$37 → $35MaintainsBuyGet Alert
07/18/2023MDGLBuy Now
Madrigal Pharmaceuticals
$278.9020.47% → $336ReiteratesBuy → BuyGet Alert
07/03/2023THTXBuy Now
Theratechnologies
$1.6719.76% → $8Assumes → HoldGet Alert
06/29/2023ICPTBuy Now
Intercept Pharma
UpgradeHold → BuyGet Alert
06/21/2023DICEBuy Now
DICE Therapeutics
$71 → $48DowngradeBuy → HoldGet Alert
06/20/2023DICEBuy Now
DICE Therapeutics
$71 → $48DowngradeBuy → HoldGet Alert
05/23/2023ICPTBuy Now
Intercept Pharma
$26 → $12MaintainsHoldGet Alert
05/22/2023DICEBuy Now
DICE Therapeutics
→ $71Initiates → BuyGet Alert
05/19/2023RZLTBuy Now
Rezolute
$4.01323.94%$16 → $17MaintainsBuyGet Alert
05/19/2023CRDLBuy Now
Cardiol Therapeutics
$1.99201.51%$5 → $6MaintainsBuyGet Alert
05/18/2023PLRXBuy Now
Pliant Therapeutics
$11.28325.53% → $48Initiates → BuyGet Alert
05/17/2023AKROBuy Now
Akero Therapeutics
$23.46151.49%$58 → $59MaintainsBuyGet Alert
05/17/2023ORMPBuy Now
Oramed Pharmaceuticals
$2.54-21.26%$3 → $2MaintainsHoldGet Alert
05/10/2023VRNABuy Now
Verona Pharma
$14.35129.97%$31 → $33MaintainsBelow AverageGet Alert
05/10/2023MDGLBuy Now
Madrigal Pharmaceuticals
$278.9020.47% → $336Reiterates → BuyGet Alert
03/21/2023AKROBuy Now
Akero Therapeutics
$23.46147.23%$50 → $58MaintainsBuyGet Alert
03/08/2023CORTBuy Now
Corcept Therapeutics
$32.49-1.51%$33 → $32MaintainsBuyGet Alert
02/28/2023MDGLBuy Now
Madrigal Pharmaceuticals
$278.9020.47%$296 → $336MaintainsBuyGet Alert
02/28/2023TVTXBuy Now
Travere Therapeutics
$8.22410.95%$44 → $42MaintainsBuyGet Alert
02/22/2023TVTXBuy Now
Travere Therapeutics
$8.22435.28%$40 → $44MaintainsBuyGet Alert
01/31/2023VTYXBuy Now
Ventyx Biosciences
$2.322227.59%$35 → $54MaintainsBuyGet Alert
01/30/2023TVTXBuy Now
Travere Therapeutics
$8.22386.62%$33 → $40MaintainsBuyGet Alert
01/12/2023ORMPBuy Now
Oramed Pharmaceuticals
$2.54DowngradeBuy → HoldGet Alert
01/10/2023AMYTBuy Now
Amryt Pharma
$19 → $17DowngradeBuy → HoldGet Alert
09/06/2022AMYTBuy Now
Amryt Pharma
→ $19Assumes → BuyGet Alert
08/17/2022VTYXBuy Now
Ventyx Biosciences
$2.321408.62%$30 → $35MaintainsBuyGet Alert
08/08/2022GLMDBuy Now
Galmed Pharmaceuticals
$0.28261.93%$75 → $15DowngradeBuy → HoldGet Alert
08/05/2022CCXIBuy Now
ChemoCentryx
→ $52DowngradeBuy → HoldGet Alert
08/04/2022CCXIBuy Now
ChemoCentryx
→ $81Assumes → BuyGet Alert
08/02/2022RZLTBuy Now
Rezolute
$4.01323.94% → $17Assumes → BuyGet Alert
07/14/2022TVTXBuy Now
Travere Therapeutics
$8.22410.95% → $42Assumes → BuyGet Alert
05/10/2022ICPTBuy Now
Intercept Pharma
$29 → $26MaintainsHoldGet Alert
04/26/2022OBSVBuy Now
ObsEva
→ $12Initiates → BuyGet Alert
03/31/2022MORFBuy Now
Morphic Holding
$34.0799.59% → $68Initiates → BuyGet Alert
03/31/2022VTYXBuy Now
Ventyx Biosciences
$2.321193.1% → $30Initiates → BuyGet Alert
03/08/2022ICPTBuy Now
Intercept Pharma
$31 → $29MaintainsHoldGet Alert
12/03/2021CRDLBuy Now
Cardiol Therapeutics
$1.99302.01%Initiates → BuyGet Alert
11/12/2021VRNABuy Now
Verona Pharma
$14.3560.28%MaintainsBuyGet Alert
08/03/2021ICPTBuy Now
Intercept Pharma
$43 → $31MaintainsHoldGet Alert
06/29/2020ICPTBuy Now
Intercept Pharma
→ $58DowngradeBuy → HoldGet Alert
09/13/2019ADVMBuy Now
Adverum Biotechnologies
$6.8616.62%$120 → $80MaintainsHoldGet Alert
08/30/2018ADVMBuy Now
Adverum Biotechnologies
$6.8660.35% → $110Initiates → BuyGet Alert